000 01572 a2200457 4500
005 20250518002712.0
264 0 _c20181126
008 201811s 0 0 eng d
022 _a1471-2334
024 7 _a10.1186/s12879-018-3400-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOliveira, Marta Iglis
245 0 0 _aVirologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure.
_h[electronic resource]
260 _bBMC infectious diseases
_cOct 2018
300 _a514 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Retroviral Agents
_xtherapeutic use
650 0 4 _aCross-Sectional Studies
650 0 4 _aDrug Resistance, Viral
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV Reverse Transcriptase
_xgenetics
650 0 4 _aHIV-1
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSalvage Therapy
650 0 4 _aTreatment Failure
650 0 4 _aViral Load
650 0 4 _aYoung Adult
700 1 _aRomão de Souza Junior, Valter
700 1 _aFernanda de Lacerda Vidal, Claudia
700 1 _aSérgio Ramos de Araújo, Paulo
773 0 _tBMC infectious diseases
_gvol. 18
_gno. 1
_gp. 514
856 4 0 _uhttps://doi.org/10.1186/s12879-018-3400-6
_zAvailable from publisher's website
999 _c28932522
_d28932522